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Abstract 
A 10-year-old female patient, being treated for dystrophic bullous epidermolysis in a 
Pediatric Hospital, was referred to our Dermoscopy Ambulatory because of a newly 
observed mole in the submandibular area. Clinically, the lesion presented as an irregular 
double-colored macule of about 2 cm in diameter, with irregular borders, suspicious of 
malignancy. Dermoscopy showed a multicomponent pattern, with multiple colors, ill-defined 
network, black blotches, streaks, multiple dots, a blue-whitish veil and granularity at the 
periphery. Although it had a clinical appearance of malignancy, dermoscopy every semester 
was proposed due to the revision of a recently described entity, named bullous 
epidermolysis nevi, that we made in these children. The fragile skin of this particular patient 
was also taken into account, and overtreatment was avoided. Bullous epidermolysis nevi is 
the term given to large, asymmetrical and often irregularly pigmented melanocytic nevi that 
occur in former areas of blistering in patients with the dystrophic forms of the disease. 
Despite its atypical clinical appearance, and sometimes also atypical dermoscopy, malignant 
transformation has not been reported yet. Similarly to recurrent nevi, where melanocytes 
proliferate in a previous area of trauma, clinical aspect, dermoscopy, and histopathology 
may tempt clinicians to diagnose benign moles as melanoma. Here we report one case of 
this entity, scarcely reported on in literature, and review clinical and dermatoscopical 
features of epidermolysis bullosa nevi confronting it with recurrent nevi. The usefulness of 
dermoscopy as a treatment strategy is stressed. 
 
Case Report 
A 10-year-old female patient was referred to our Dermoscopy Ambulatory because of a new 
pigmented lesion noted 6 months before. She was receiving treatment for dystrophic bullous 
epidermolysis in a Pediatric Hospital. Her mother reported progressive growth and color change of 
this lesion since its appearance. In clinical examination, the patient presented pseudosyndactily and  
Case Rep Dermatol 2011;3:235–239 
DOI: 10.1159/000334832 
Published online: 
November 29, 2011 
© 2011 S. Karger AG, Basel 
ISSN 1662–6567 
www.karger.com/cde 
 
 
 
236 
sparse exulcerations in the areas of previous bullae. In the submandibular area, an irregular 
pigmented mole of about 2 cm in diameter was observed (fig. 1). Dermoscopy showed a 
multicomponent pattern, with multiple colors, ill-defined network, black blotches, streaks, multiple 
dots, a blue-whitish veil and granularity at the periphery (fig. 2). Due to the possibility of a bullous 
epidermolysis nevi, the authors decided to follow up clinically and with dermoscopy every 6 months. 
This follow-up was delayed due to infectious complications of the disease, leading to hospitalization of 
the child. 
Discussion 
Epidermolysis bullosa (EB) represents a heterogeneous group of mechano-bullous 
disorders genetically rooted in an intrinsic defect of the structural components of the 
basement membrane zone [1].The development of lesions with atypical clinical 
features in patients with different forms of EB has occasionally been pointed out. The 
recessive variants of the disease account for the vast majority of the reported cases. 
There are a few reports in the literature of moles suspicious of malignancy in 
patients with bullous epidermolysis, recently classified in a new entity named EB nevi. 
They commonly arise in areas of previous bullae or erosions, tend to present rapid 
growth, and usually fulfill the clinical ABCD criteria for atypical or malignant 
melanocytic proliferations. These nevi are dynamic, beginning as flat pigmented lesions 
and becoming papillated, loosing pigment or even becoming more pigmented. So far, no 
evolution to malignancy has been described, but the number of EB nevi studied is not 
large enough to completely rule out the possibility that they might be melanoma 
precursor lesions. 
Two pathogenic theories about the development of EB nevi have been proposed. 
According to one of them, the repetitive disruption of the basement membrane leads 
single melanocytes or local nevus cells to break senescence and undergo proliferation 
[2, 3]. According to the other theory, viable melanocytes/nevus cells freely float the 
cavity of an EB blister [4] and, after settling down, proliferate excessively in the 
microenvironment of epidermal regeneration in an arbitrary arrangement [5–7]. 
Cytokines and growth factors, such as interleukin 8, granulocyte-macrophage colony-
stimulating factor, prostaglandin E2 and leukotriene B4 have been detected in blister 
fluid [7], which might potentiate melanocytic proliferation. Understanding the 
pathogenesis may help disclose their benign nature, in spite of false-positive scores 
with application of dermoscopic algorithms. 
Interestingly, EB nevi show analogy to recurrent nevi after incomplete surgical 
excision or trauma of a nevus. Such traumatized moles also frequently mimic 
melanoma, clinically, dermoscopically and histologically. While dermoscopy and, more 
recently, reflectance confocal microscopy (RCM) have proven to be valuable tools in the 
diagnosis of most pigmented lesions, little is currently known about their clinical value 
in the differential diagnosis of recurrent melanocytic proliferations. Longo et al. [8] 
investigated dermoscopic and RCM features of seven histopathologically diagnosed 
cases of recurrent melanocytic proliferations. Repigmentation occurring within the scar 
through dermoscopy was a clue suggestive for nevi, while a lateral spreading of the 
pigmentation, extending from the border of the scar towards the surrounding normal 
skin was observed in all cases of melanoma. Although scar pigmentation is a frequent 
phenomenon, there are few papers on this subject [9]. Yoshida et al. [10] reported the  
Case Rep Dermatol 2011;3:235–239 
DOI: 10.1159/000334832 
Published online: 
November 29, 2011 
© 2011 S. Karger AG, Basel 
ISSN 1662–6567 
www.karger.com/cde 
 
 
 
237 
case of a 47-year-old patient with a mole on her left arm since childhood, where a 
darker pigmentation had been observed. Through dermoscopy a starburst pattern was 
seen, and histopathology diagnosed a melanocytic nevus with partial recurrence after 
minor trauma. Similarly to what happens in EB nevi, it was speculated that stimulation 
of melanin production might have been induced in the wound healing process. 
Lanschuetzer et al. [11] used dermoscopy to test usefulness of this technique in 
distinguishing EB nevi from melanoma. Twenty-three nevi of 11 patients were analyzed 
with a dermoscope. Twenty of the 23 lesions were classified as having a 
multicomponent pattern or showed a 3-structure type pattern, both highly suggestive 
of malignant melanoma. More than half of the lesions achieved a high score for the 
ABCD and 7-point checklist. Nevertheless, strong morphologic indicators for invasive 
cutaneous melanoma, or a blue-whitish veil, which represents a melanoma-induced 
acanthotic epidermis, were not observed. Although it was often possible to estimate the 
benign nature of the moles, unequivocal discrimination from melanoma could not be 
made, and regular follow-up was proposed. 
Schiffner et al. [12] proposed a progression model of lentigo maligna located on the 
face. According to their findings, slate-gray dots are an early feature of lentigo maligna, 
which can increase to globules. Short streaks can be detected, and can progress to very 
specific rhomboidal structures. Melanoma cells within the follicles can invade the 
adjacent dermis, resulting in bizarre globules at the periphery of the follicle. During 
further tumor progression, rhomboidal structures become broader and hair follicles 
are obliterated. 
Taking into account all the aspects of EB nevi described above, it can be considered 
an exception among melanocytic lesions. If not aware of this particular nevi, clinicians 
might be tempted to establish a more aggressive treatment, when clinical and 
dermoscopic semestral review would be a secure and more convenient therapeutic 
strategy for these fragile skin patients. Here dermoscopy presents as an essential 
technique to prevent overtreatment. 
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Fig. 1. Clinical aspect of the lesion. 
 
 
 
Fig. 2. Dermoscopic aspect of the mole. 
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